Updated on 24 January 2024
File name
ie-spc v8-regaine for women foam-2443.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Updated on 24 January 2024
File name
ie-leaflet-regaine-for-women-foam-2443.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 19 June 2023
File name
ie-pl-proposed-clean-regaine for women foam-2303.pdf
Reasons for updating
- Change to section 2 - excipient warnings
- Change to section 6 - date of revision
Updated on 19 June 2023
File name
ie-spc v7-proposed-clean-regaine for women foam-2303.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Updated on 24 February 2023
File name
ie-spc v6 regaine for women foam-2246.pdf
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Updated on 24 February 2023
File name
ie-leaflet-regaine-for-women-foam-2246.pdf
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 02 February 2023
File name
ie-leaflet-proposed-clean-regaine-for-women-foam-2307.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 07 May 2021
File name
ie-spc v5-clean regaine for women foam - 2144.pdf
Reasons for updating
- Change to section 9 - Date of first authorisation/renewal of the authorisation
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Updated on 13 February 2019
File name
ie-pl Regaine for Women Foam RGG02 1888.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 13 February 2019
File name
ie-spc v4 RGG02 1888.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Updated on 20 August 2018
File name
ie-pl clean RGG02 1708.pdf
Reasons for updating
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - driving and using machines
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 20 August 2018
File name
ie-spc v3 RGG02 1708.pdf
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.7 - Effects on ability to drive and use machines
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Updated on 07 March 2017
Reasons for updating
- New SPC for new product
Legal category:Supply through pharmacy only
Updated on 07 March 2017
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
4.8 Undesirable effects
[...]
System Organ Class and Frequency |
Adverse Drug Reaction
|
Immune system disorders
Not known |
Allergic reactions including a (with symptoms such as e.g. oedema of lips, mouth, tongue and pharynx, swelling of lips, tongue and oropharynx)
Hypersensitivity (including face oedema, generalised erythema, pruritus generalised, swelling face, and throat tightness)
Allergic contact dermatitis
|
[...]
10. DATE OF REVISION OF THE TEXT
January 2016January 2017
Updated on 01 March 2017
File name
PIL_16983_78.pdf
Reasons for updating
- New PIL for new product
Updated on 01 March 2017
Reasons for updating
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 09 November 2016
Reasons for updating
- New SPC for new product
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Updated on 07 November 2016
Reasons for updating
- New PIL for new product